The stigma of postpartum depression is so strong that celebrities like Brooke Shields, Marie Osmond, Adele and Cheryl Tiegs have felt the need to come out in the open to help improve the lives of young mothers.
However, there are no specific medical treatments for postpartum depression – including currently marketed antidepressants – that have been approved by the US FDA. The results of preliminary evaluations of the available medications have at best been mixed.
In this context, NWCRC is evaluating a potential new investigational medication that targets hormonal changes associated with pregnancy and depression after childbirth. However, this cannot be done without the help of research volunteers.
The nature of depression after childbirth
Depression after child birth is not uncommon. Mothers of all ethnicities and socioeconomic classes are impacted by postpartum depression and the complicated nature of experiencing depression while raising a newborn.
Depression after child birth typically sets in within 30 days and is complicated in that the depressive symptoms of overwhelming sadness, guilt and grief are compounded by the difficulties of raising an infant and the challenges of overcoming the bodily changes that accompany pregnancy.
Brooke Shields – Scary Postpartum depression
About the Study
The postpartum depression study consists of an intense treatment period of the study medication. Although many mothers with postpartum depression suffer from lactation problems or have stopped lactating, we are here for consultation about managing lactation during the period of study when medication is taken.
Should you qualify and decide to pursue the postpartum depression study all of the assessments done throughout the study are free of cost, study medication is also provided at no cost and you are compensated for your time.
Your first visit to Northwest Clinical Research Center will consist of a free mental health evaluation. This will include a detailed evaluation of your depression symptoms.